Infectious diseases are caused by pathogens such as bacteria, viruses, parasites, fungi. These diseases will spread, directly or indirectly from one person to another person. So, anti-infective drugs are used to prevent the growth of such diseases. These drugs directly targets the causative agent and hinders the growth of the disease. Infectious diseases such as malaria, HIV, tuberculosis, influenza, salmonella pose a major challenge for public.
Some of the major factor that are driving the Europe infectious disease Market are increasing occurrence of infectious diseases, increasing health care expenditure and increasing geriatric population, growing healthcare awareness, increasing government funding’s in developing countries. Generic erosion, Patent expiration of infectious disease drugs are the factors that are hindering the growth of the market.
Based on Treatment, the market is segmented into Drugs and Vaccines. The drugs are further segmented into oral administration, topical, injections and others. Based on target organism the market is segment into antibacterial, antifungal, antiviral, antiparasitic and others. Based on infection type the market is segmented into Bacterial, viral, fungal, parasite and others. Based on distribution channels the market is categorized into hospitals, clinics and others. Based on Geography, the Europe Infectious disease therapeutics market is analyzed under various regions namely U.K, Germany, France, Italy and Spain
Market Segmentation:
1 Product
1.1 Introduction
1.2 Instruments & Analyzers
1.3 Consumables
1.3.1 Assays and Reagents
1.4 Services & Softwares
1.5 Y-o-Y Growth Analysis, By Product
1.6 Market Attractiveness Analysis, By Product
1.7 Market Share Analysis, By Product
2 Techniques
2.1 Introduction
2.2 Traditional Diagnostic Techniques
2.2.1 Immunodiagnostics
2.2.2 Microscopy
2.2.3 Biochemical Characterization
2.3 Molecular Diagnostics
2.3.1 PCR
2.3.2 INAAT
2.3.2 Hybridization
2.3.3 DNA Sequencing & NGS
2.3.4 Microarray
2.3.5 Others
2.4 Y-o-Y Growth Analysis, By Technique
2.5 Market Attractiveness Analysis, By Technique
2.6 Market Share Analysis, By Technique
3 Applications
3.1 Introduction
3.2 Hepatitis B
3.3 Hepatitis C
3.4 Human Immunodeficiency Virus (HIV)
3.5 Tuberculosis (TB)
3.6 Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG)
Some of the key players influencing the Europe Infectious disease Therapeutics Market F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer, Achillion Pharmaceuticals, Novartis, AbbVie, Astellas Pharma, AstraZeneca, Auritec Pharmaceuticals, Bayer, Bristol-Myers Squibb, Chimerix Pharmaceuticals, Cubist, Eli Lilly, Isis Pharmaceuticals, Mitsubishi Tanabe Pharma, pSivida, Sanofi.
About Market Data Forecast Market Data Forecast is a well versed market research firm catering solutions in the fields of market research, business intelligence and consulting. With a profound knowledge about the global market activities coupled with a customized approach. We render services in the most gripping markets like healthcare, agriculture and food & Beverages
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
